Serum Institute resumes COVID-19 vaccine exports
PTI, Nov 26, 2021, 6:29 PM IST
Serum Institute of India — the world’s largest vaccine maker — on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
The vaccine maker has cumulatively produced 1.25 billion doses so far, a company statement said.
”The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries via the COVAX mechanism,” it said. ”SII’s supply of doses via COVAX is expected to increase substantially into Quarter 1 2022,” it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
‘Shehzada’ dig: 3 generations of Nehru-Gandhi family sacrificed themselves for country, says Sharad Pawar
Delhi cops question Youth Cong leader in MP’s Chhatarpur over fake video of Shah
Poor people have more children, why only Muslims are being targeted: Kharge asks PM
HC rejects bail prayer of incarcerated former WB minister Partha Chatterjee in money laundering case
SC questions ED on timing of Kejriwal’s arrest ahead of LS polls, seeks its reply
MUST WATCH
Latest Additions
‘Shehzada’ dig: 3 generations of Nehru-Gandhi family sacrificed themselves for country, says Sharad Pawar
Rinku Singh a casualty of IPL’s ‘Impact Player’ rule: Report quotes BCCI source on T20 World Cup
Delhi cops question Youth Cong leader in MP’s Chhatarpur over fake video of Shah
Kumaraswamy and Shivakumar spar over sex scandal involving Hassan MP
Poor people have more children, why only Muslims are being targeted: Kharge asks PM